Illi­nois col­lege of phar­ma­cy pe­ti­tions FDA to re­move clin­i­cal re­quire­ments for biosim­i­lars

The Uni­ver­si­ty of Illi­nois Chica­go’s Col­lege of Phar­ma­cy last week pe­ti­tioned the FDA to re­move clin­i­cal ef­fi­ca­cy test­ing for all new biosim­i­lars — and not just …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.